Handelsbanken Fonder AB
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1398318
STOCKHOLM, V7
Position in ARWR
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$3,488,628
+$805,068 QoQ
Shares Held
42,800
0.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#149
of 497 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. ARWR ranks #26 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
218,292 | $108,432,185 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
631,899 | $49,458,734 | |
| 3 | ARGX |
Argenx SE
|
52,653 | $48,849,873 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
212,275 | $39,754,862 | |
| 5 | CYTK |
Cytokinetics Inc
|
405,000 | $34,501,950 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
90,407 | $33,601,569 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,328 | $32,628,601 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
107,255 | $32,286,972 |
All Filings in ARWR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,488,628 | 42,800 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $2,683,560 | 42,800 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,562,654 | 38,600 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,286,477 | 37,300 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $589,340 | 37,300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $524,888 | 41,200 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $774,560 | 41,200 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $691,509 | 35,700 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $792,695 | 30,500 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $657,800 | 23,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $660,960 | 21,600 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $540,087 | 20,100 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $716,766 | 20,100 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $431,800 | 17,000 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $689,520 | 17,000 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $561,850 | 17,000 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $598,570 | 17,000 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $781,830 | 17,000 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,332,630 | 20,100 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,279,815 | 20,500 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,532,170 | 18,500 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,226,735 | 18,500 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,419,505 | 18,500 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $680,348 | 15,800 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $682,402 | 15,800 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||